Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Avanos Medical stock | 42.64

Own Avanos Medical stock in just a few minutes.

Posted

Fact checked

Avanos Medical, Inc is a medical devices business based in the US. Avanos Medical shares (AVNS) are listed on the NYSE and all prices are listed in US Dollars. Avanos Medical employs 4,700 staff and has a trailing 12-month revenue of around USD$705.3 million.

How to buy shares in Avanos Medical

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Avanos Medical. Find the stock by name or ticker symbol: AVNS. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Avanos Medical reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$42.64, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Avanos Medical, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Avanos Medical. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Avanos Medical's share price?

Since the stock market crash in March caused by coronavirus, Avanos Medical's share price has had significant positive movement.

Its last market close was USD$42.64, which is 27.91% up on its pre-crash value of USD$30.74 and 119.12% up on the lowest point reached during the March crash when the shares fell as low as USD$19.46.

If you had bought USD$1,000 worth of Avanos Medical shares at the start of February 2020, those shares would have been worth USD$750.47 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,550.39.

Avanos Medical share price

Use our graph to track the performance of AVNS stocks over time.

Avanos Medical shares at a glance

Information last updated 2020-10-19.
Latest market close USD$42.64
52-week range USD$19.46 - USD$48.07
50-day moving average USD$34.2535
200-day moving average USD$31.0099
Wall St. target price USD$36.6
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.561

Buy Avanos Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Avanos Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Avanos Medical price performance over time

Historical closes compared with the close of $42.64 from 2020-11-16

1 week (2020-11-20) 0.35%
1 month (2020-10-30) 20.62%
3 months (2020-08-28) 30.16%
6 months (2020-05-29) 46.73%
1 year (2019-11-29) 23.02%
2 years (2018-11-29) -8.20%
3 years (2017-11-29) -11.94%
5 years (2015-11-27) 29.96%

Is Avanos Medical under- or over-valued?

Valuing Avanos Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avanos Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avanos Medical's EBITDA

Avanos Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$34.2 million.

The EBITDA is a measure of a Avanos Medical's overall financial performance and is widely used to measure a its profitability.

Avanos Medical financials

Revenue TTM USD$705.3 million
Gross profit TTM USD$402.2 million
Return on assets TTM -0.25%
Return on equity TTM -1.33%
Profit margin -2.4%
Book value $26.393
Market capitalisation USD$1.8 billion

TTM: trailing 12 months

Shorting Avanos Medical shares

There are currently 2.4 million Avanos Medical shares held short by investors – that's known as Avanos Medical's "short interest". This figure is 19.4% up from 2.0 million last month.

There are a few different ways that this level of interest in shorting Avanos Medical shares can be evaluated.

Avanos Medical's "short interest ratio" (SIR)

Avanos Medical's "short interest ratio" (SIR) is the quantity of Avanos Medical shares currently shorted divided by the average quantity of Avanos Medical shares traded daily (recently around 272510.75514874). Avanos Medical's SIR currently stands at 8.74. In other words for every 100,000 Avanos Medical shares traded daily on the market, roughly 8740 shares are currently held short.

However Avanos Medical's short interest can also be evaluated against the total number of Avanos Medical shares, or, against the total number of tradable Avanos Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Avanos Medical's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Avanos Medical shares in existence, roughly 50 shares are currently held short) or 0.0571% of the tradable shares (for every 100,000 tradable Avanos Medical shares, roughly 57 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Avanos Medical.

Find out more about how you can short Avanos Medical stock.

Avanos Medical share dividends

We're not expecting Avanos Medical to pay a dividend over the next 12 months.

Avanos Medical share price volatility

Over the last 12 months, Avanos Medical's shares have ranged in value from as little as $19.46 up to $48.07. A popular way to gauge a stock's volatility is its "beta".

AVNS.US volatility(beta: 1.01)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Avanos Medical's is 1.0121. This would suggest that Avanos Medical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Avanos Medical overview

Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Its product portfolio includes digestive health products, including enteral feeding tubes and solutions; respiratory health products, such as closed airway suction systems and oral care kits; and acute pain products comprising surgical pain pumps, and cold and compression therapy systems, as well as interventional pain management solutions that include minimally invasive interventional pain therapies. The company sells its products under the MIC-KEY, CORPAK, NEOMED, BALLARD, MICROCUFF, ENDOCLEAR, ON-Q, AMBIT, GAME READY, and COOLIEF brand names. It markets its products directly to hospitals and other healthcare providers, and through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site